VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 101 filers reported holding VOYAGER THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 17.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $683,341 | -29.8% | 88,173 | +3.7% | 0.00% | – |
| Q2 2023 | $973,880 | +914.9% | 85,055 | +583.4% | 0.00% | – |
| Q1 2023 | $95,959 | +26.4% | 12,446 | 0.0% | 0.00% | – |
| Q4 2022 | $75,921 | +2.6% | 12,446 | 0.0% | 0.00% | – |
| Q3 2022 | $74,000 | 0.0% | 12,446 | 0.0% | 0.00% | – |
| Q2 2022 | $74,000 | -39.3% | 12,446 | -21.8% | 0.00% | – |
| Q1 2022 | $122,000 | -74.2% | 15,910 | -86.1% | 0.00% | – |
| Q2 2021 | $472,000 | -39.3% | 114,256 | -30.7% | 0.00% | – |
| Q1 2021 | $777,000 | -36.0% | 164,879 | -2.9% | 0.00% | – |
| Q4 2020 | $1,215,000 | -31.9% | 169,890 | +1.6% | 0.00% | -100.0% |
| Q3 2020 | $1,785,000 | -15.2% | 167,227 | +0.3% | 0.00% | 0.0% |
| Q2 2020 | $2,104,000 | +11.6% | 166,678 | -19.1% | 0.00% | 0.0% |
| Q1 2020 | $1,886,000 | -33.9% | 206,102 | +0.7% | 0.00% | -50.0% |
| Q4 2019 | $2,854,000 | -16.8% | 204,587 | +2.7% | 0.00% | 0.0% |
| Q3 2019 | $3,430,000 | -10.0% | 199,288 | +42.4% | 0.00% | 0.0% |
| Q2 2019 | $3,809,000 | +58.8% | 139,916 | +11.7% | 0.00% | 0.0% |
| Q1 2019 | $2,398,000 | +123.7% | 125,269 | +9.9% | 0.00% | +100.0% |
| Q4 2018 | $1,072,000 | -51.2% | 114,000 | -1.7% | 0.00% | 0.0% |
| Q3 2018 | $2,195,000 | +10.6% | 115,987 | +14.2% | 0.00% | 0.0% |
| Q2 2018 | $1,985,000 | +21.8% | 101,576 | +17.1% | 0.00% | 0.0% |
| Q1 2018 | $1,630,000 | +27.4% | 86,727 | +12.6% | 0.00% | 0.0% |
| Q4 2017 | $1,279,000 | +24.7% | 77,038 | +54.7% | 0.00% | 0.0% |
| Q3 2017 | $1,026,000 | +293.1% | 49,788 | +71.5% | 0.00% | – |
| Q2 2017 | $261,000 | -31.9% | 29,035 | +0.4% | 0.00% | – |
| Q1 2017 | $383,000 | +7.6% | 28,921 | +3.7% | 0.00% | – |
| Q4 2016 | $356,000 | +9.9% | 27,895 | +3.4% | 0.00% | – |
| Q3 2016 | $324,000 | +12.1% | 26,971 | +2.6% | 0.00% | – |
| Q2 2016 | $289,000 | +91.4% | 26,281 | +52.2% | 0.00% | – |
| Q1 2016 | $151,000 | -59.5% | 17,271 | +1.5% | 0.00% | -100.0% |
| Q4 2015 | $373,000 | – | 17,016 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $45,697,000 | 3.92% |
| ARMISTICE CAPITAL, LLC | 3,392,000 | $24,253,000 | 0.82% |
| Bellevue Group AG | 2,712,083 | $19,391,000 | 0.22% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 141,924 | $1,015,000 | 0.17% |
| XTX MARKETS LLC | 10,578 | $76,000 | 0.16% |
| Aevitas Wealth Management, Inc. | 22,150 | $158,000 | 0.12% |
| Virtus ETF Advisers LLC | 35,079 | $251,000 | 0.10% |
| HITE Hedge Asset Management LLC | 29,357 | $210,000 | 0.05% |
| LINCOLN CAPITAL CORP | 10,000 | $72,000 | 0.05% |
| CIM INVESTMENT MANAGEMENT INC | 18,745 | $134,000 | 0.04% |